首页 正文

Evaluation of WO2017098421: GSK's benzothiazine compounds as CD73 inhibitor filings

{{output}}
There are considerable interests in the development of novel small-molecule CD73 inhibitors for the treatment of cancers, autoimmune diseases, precancerous syndromes, and other diseases associated with CD73 activity. Areas covered: The application claims novel... ...